| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.66 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |